Fu X - Search Results

1

Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles.

Fu X, Tao L, Wang PY, Cripe TP, Zhang X. Fu X, et al. Oncotarget. 2018 Apr 20;9(30):21348-21358. doi: 10.18632/oncotarget.25096. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765544 Free PMC article.

2

An HSV-2 based oncolytic virus can function as an attractant to guide migration of adoptively transferred T cells to tumor sites.

Fu X, Rivera A, Tao L, Zhang X. Fu X, et al. Oncotarget. 2015 Jan 20;6(2):902-14. doi: 10.18632/oncotarget.2817. Oncotarget. 2015. PMID: 25460506 Free PMC article.

3

Genetically coating oncolytic herpes simplex virus with CD47 allows efficient systemic delivery and prolongs virus persistence at tumor site.

Fu X, Tao L, Zhang X. Fu X, et al. Oncotarget. 2018 Oct 2;9(77):34543-34553. doi: 10.18632/oncotarget.26167. eCollection 2018 Oct 2. Oncotarget. 2018. PMID: 30349648 Free PMC article.

4

Arming HSV-Based Oncolytic Viruses with the Ability to Redirect the Host's Innate Antiviral Immunity to Attack Tumor Cells.

Fu X, Tao L, Wu W, Zhang X. Fu X, et al. Mol Ther Oncolytics. 2020 Sep 6;19:33-46. doi: 10.1016/j.omto.2020.09.002. eCollection 2020 Dec 16. Mol Ther Oncolytics. 2020. PMID: 33024817 Free PMC article.

5

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect.

Fu X, Tao L, Jin A, Vile R, Brenner MK, Zhang X. Fu X, et al. Mol Ther. 2003 Jun;7(6):748-54. doi: 10.1016/s1525-0016(03)00092-3. Mol Ther. 2003. PMID: 12788648 Free article.

6

Effective treatment of pancreatic cancer xenografts with a conditionally replicating virus derived from type 2 herpes simplex virus.

Fu X, Tao L, Li M, Fisher WE, Zhang X. Fu X, et al. Clin Cancer Res. 2006 May 15;12(10):3152-7. doi: 10.1158/1078-0432.CCR-06-0045. Clin Cancer Res. 2006. PMID: 16707615

7

Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.

Li H, Dutuor A, Tao L, Fu X, Zhang X. Li H, et al. Among authors: fu x. Clin Cancer Res. 2007 Jan 1;13(1):316-22. doi: 10.1158/1078-0432.CCR-06-1625. Clin Cancer Res. 2007. PMID: 17200370

8

Antitumor effects of two newly constructed oncolytic herpes simplex viruses against renal cell carcinoma.

Fu X, Nakamori M, Tao L, Amato R, Zhang X. Fu X, et al. Int J Oncol. 2007 Jun;30(6):1561-7. Int J Oncol. 2007. PMID: 17487379

9

Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication.

Fu X, Tao L, Rivera A, Zhang X. Fu X, et al. Int J Cancer. 2011 Sep 15;129(6):1503-10. doi: 10.1002/ijc.25808. Epub 2011 Feb 26. Int J Cancer. 2011. PMID: 21128236 Free PMC article.

10

Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells.

Fu X, Rivera A, Tao L, De Geest B, Zhang X. Fu X, et al. Mol Ther. 2012 Feb;20(2):339-46. doi: 10.1038/mt.2011.265. Epub 2011 Dec 6. Mol Ther. 2012. PMID: 22146341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,722 results

Search Page

Filters